DYADIC INTERNATIONAL INC Operating Lease, Liability, Current
DYADIC INTERNATIONAL INC (DYAI) had Operating Lease, Liability, Current of $5.05 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-12
- 2026-06-30: Operating Lease, Liability, Current $5.05K.
- 2026-03-31: Operating Lease, Liability, Current $20.00K.
- 2025-12-31: Operating Lease, Liability, Current $34.62K.
- 2025-09-30: Operating Lease, Liability, Current $48.93K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $5.05K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $20.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $34.62K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $48.93K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $57.58K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $55.90K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $54.25K 10-K · filed 2026-03-25 |
| 2024-09-30 | $53.48K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $51.08K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $49.55K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $48.06K 10-K · filed 2025-03-26 |
| 2023-09-30 | $46.60K 10-Q · filed 2023-11-08 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |